Reticular dysgenesis is an autosomal recessive form of human severe combined immunodeficiency characterized by an early differentiation arrest in the myeloid lineage and impaired lymphoid maturation. In addition, affected newborns have bilateral sensorineural deafness. Here we identify biallelic mutations in AK2 (adenylate kinase 2) in seven individuals affected with reticular dysgenesis. These mutations result in absent or strongly decreased protein expression. We then demonstrate that restoration of AK2 expression in the bone marrow cells of individuals with reticular dysgenesis overcomes the neutrophil differentiation arrest, underlining its specific requirement in the development of a restricted set of hematopoietic lineages. Last, we establish that AK2 is specifically expressed in the stria vascularis region of the inner ear, which provides an explanation of the sensorineural deafness in these individuals. These results identify a previously unknown mechanism involved in regulation of hematopoietic cell differentiation and in one of the most severe human immunodeficiency syndromes.
Reticular dysgenesis is an autosomal recessive form of human severe combined immunodeficiency characterized by an early differentiation arrest in the myeloid lineage and impaired lymphoid maturation. In addition, affected newborns have bilateral sensorineural deafness. Here we identify biallelic mutations in AK2 (adenylate kinase 2) in seven individuals affected with reticular dysgenesis. These mutations result in absent or strongly decreased protein expression. We then demonstrate that restoration of AK2 expression in the bone marrow cells of individuals with reticular dysgenesis overcomes the neutrophil differentiation arrest, underlining its specific requirement in the development of a restricted set of hematopoietic lineages. Last, we establish that AK2 is specifically expressed in the stria vascularis region of the inner ear, which provides an explanation of the sensorineural deafness in these individuals. These results identify a previously unknown mechanism involved in regulation of hematopoietic cell differentiation and in one of the most severe human immunodeficiency syndromes.
The term 'reticular dysgenesis' was coined in 1959 by de Vall and Seyneheve 1 and relates to the histological findings in primary and secondary lymphohematopoietic organs, where the scarcity of cells highlights the prominent reticular tissue framework. The lack of polymorphonuclear neutrophils (PMNs) in affected individuals is responsible for the occurrence of severe infections earlier than is usually observed in other forms of SCID 2, 3 . Reticular dysgenesisassociated neutropenia is characterized by lack of responsiveness to granulocyte-colony stimulating factor (G-CSF) 4 . The only available treatment for reticular dysgenesis is allogeneic hematopoietic stem cell transplantation (HSCT), which formally demonstrates that the inherited defect is cellular and not microenvironmental 5 .
In order to determine the molecular genetic basis of reticular dysgenesis, we took advantage of three separate consanguineous kindreds (family A, B and C, Fig. 1a) . A genome-wide linkage scan generated a significant, multipoint lod score of 4.47 in a single region located on the short arm of chromosome 1 (1p31-p34). We then refined the map by genotyping 17 additional microsatellite markers in this region. The 90% confidence interval (CI) of the region of interest covered B4 Mb, stretching from 30.89 to 34.79 Mb (Fig. 1b) . Notably, two subjects originating from the same geographical area (P1 and P2) were found to be homozygous for the same haplotype in the region between 32.8 and 34.79 Mb (including 18 SNPs and 8 microsatellite markers), which strongly suggested a founder effect in these two families and reduced the prime region of interest to B2 Mb. We then fully sequenced the prime region of interest (Supplementary Table 1 online). Subjects from the three consanguineous families (P1, P2 and P3) were found to be homozygous for mutations in the gene encoding adenylate kinase 2 (AK2). Similarly, we found AK2 mutations in four additional individuals with reticular dysgenesis born to nonconsanguineous parents (Fig. 1a) .
The AK2 gene encodes two types of mRNA (expressed via an alternative splicing mechanism): AK2A, which has six exons, and AK2B, which includes an additional seventh exon located in the 3¢ part of the gene. AK2A and AK2B encode, respectively, a 239-amino-acid and a 232-amino-acid protein 6 .
Homozygous mutations were prevalent among the defects found in the seven affected individuals analyzed (Fig. 1c) : three individuals (P1, P2 and P5) showed homozygous missense mutations of highly conserved amino acid residues ( Supplementary Fig. 1 online) , two individuals (P3 and P6) carried a homozygous deletion (1 bp and B5 kb, respectively) that generated a premature stop codon, and one case (P7) carried a homozygous nonsense mutation. P4 was found to be a compound heterozygote with a missense mutation and an exon 2 deletion (Fig. 1c,d) . All mutations affect different key domains of the AK2 protein (Fig. 1c) and are thus expected to severely hamper its stability and/or function. In all cases, the parents were found to be heterozygous for the mutated AK2 allele and the healthy siblings that we tested were heterozygous or homozygous for the wild-type allele (Fig. 1a) .
AK2 is expressed in the mitochondrial intermembrane space in a variety of tissues, such as the liver, kidney, spleen and heart 6 . We assessed the expression of the AK2 gene in fibroblasts (either primary cultures or SV40-transformed cells) obtained from subjects P1, P3, P5 and P6 and in a B-EBV cell line from subject P2. Using protein blot analysis, we did not detect any AK2 protein in the fibroblasts from P1, P3 and P6 (Fig. 2a) . AK2 protein was detected in the B-EBV cell line and in fibroblasts derived from P2 and P5, respectively, but at markedly lower levels than in control cells (Fig. 2a) . In contrast to the AK2 protein, AK2 mRNA was detected by RT-PCR at levels comparable to those found in control cell lines in all samples analyzed (Fig. 2b) . These data strongly suggest that reticular dysgenesis results from loss-of-function mutations in the AK2 gene.
Analysis of the immunological characteristics of individuals with reticular dysgenesis showed that the profound neutropenia was invariably associated with an equally profound T and natural killer (NK) cell lymphopenia, whereas the B cell lineage was variably affected ( Table 1 ). The circulating monocyte count was normal or above normal, and red blood cell and platelet counts were normal or slightly diminished, as also observed previously 7 . Morphological examination of the bone marrow revealed a profound block in granulopoiesis, with no detectable cells beyond the myelocyte stage, thus indicating that reticular dysgenesis corresponds to a selective developmental arrest along T, NK lymphoid and granulocytic myeloid pathways. In In six subjects, the mutations were homozygous (**) and in one subject, they were heterozygous (*). n.d., not determined. semisolid medium, CD34 + cells isolated from the bone marrow of P2 did not generate granulocytic colonies, and only a few myeloblasts and erythroblasts were observed before and after culture ( Supplementary  Fig. 2a online) . In subject P2, after CD34 + cells were cultured in the presence of SCF, FLT-3L and GM-CSF or G-CSF cytokines, CD15 + CD11b + neutrophil cell counts were two and four times lower, respectively, than in control cord blood cell cultures ( Supplementary  Fig. 2b ), suggesting a potential role for AK2 in the G-CSF receptormediated myeloid differentiation. This is in agreement with the G-CSF refractory neutropenia observed in affected individuals.
As a first step toward elucidating the function of AK2 in hematopoiesis, we carried out an RT-PCR AK2 gene expression profile analysis, which showed AK2 upregulation in the various hematopoietic subsets as compared to a fibroblast cell line ( Supplementary Fig. 3 online). These results fit with a differential and specific role of AK2 in different cell types.
In order to prove unequivocally that AK2 mutations were responsible for the profound neutropenia, we set out to restore myeloid differentiation in vitro by transducing bone marrow CD34 + cells from affected individuals with a lentivirus encoding cDNA of both AK2A + AK2B. Granulocyte/granulocyte-monocyte (G/GM) colonies derived from bone marrow cells of P3 and transduced with a control GFP vector were characterized by the presence of immature myeloblasts, promyelocytes, and very few mature myelocytes and polynucleated cells. In contrast, G/GM colonies derived from bone marrow cells transduced with AK2A, AK2B and GFP (AK2A/B + GFP) contained around 46% of mature myeloid cells, metamyelocytes and polymorphonuclear cells (Fig. 3a,b) , showing the unambiguous characteristics of mature myeloid cells. These mature granulocytes were very similar to those observed in colonies cultured from control healthy cord blood cells (Fig. 3a) . We confirmed these morphological observations by flow cytometry analysis (Fig. 3c) and showed that the CD15 + CD11b + cell count was 3.7-fold higher in the AK2A/B + GFP condition than in the GFP condition (Fig. 3d) . Furthermore, the overall count of GFP + AK2 + complemented cells in the G/GM colonies was 53-fold higher than that of GFP + cells isolated from noncomplemented bone marrow cells (Fig. 3d) . Restoration of neutrophil differentiation was confirmed in bone marrow cell from P6 ( Supplementary Fig. 4 online) . These data demonstrate that AK2 complementation corrects the defective granulopoiesis in reticular dysgenesis. In order to confirm the specific role of AK2 in neutrophil differentiation, we developed a RNA interference strategy through lentiviral-mediated gene transfer of AK2 short hairpin RNAs (shAK2), using the previously published shAK2 target sequence 8 . The downregulation of AK2 expression in human CD34 + cell induced a 17-to 27-fold reduction in myeloid cells and granulocyte precursors associated with a profound arrest in neutrophil differentiation as determined by counting of CD15 + CD11b + cells and by morphological examination ( Supplementary Fig. 5 online) . Conversely, no decrease in the proliferation rate was observed in human primary fibroblasts transduced with the same AK2 shRNA lentivirus vector (data not shown).
In order to investigate the pathogenic process underlying the hearing impairment observed in all 7 subjects with reticular dysgenesis, we analyzed the distribution of AK2 in the mouse inner ear by immunohistolabeling. AK2 expression could not be detected in the vestibule at any developmental stage (Fig. 4a) . In contrast, assessment of the cochlea revealed an intense AK2 staining observed uniquely in the stria vascularis at postnatal day 7 but not at birth (Fig. 4b,c) . Co-immunolabeling of AK2 and isolectin showed that AK2 is present within the lumen of the stria vascularis capillaries (Fig. 4d) , thus suggesting that it could be here functioning as an ecto-enzyme. Notably, we did not detect AK2 in the capillaries or vessels of the adjacent connective tissue (Fig. 4d) .
Our data provide evidence that recessive mutations of the human AK2 gene are responsible for reticular dysgenesis, a very rare form of SCID characterized by a profound impairment of the lymphomyeloid compartment associated with deafness. AK2 has a key role during development, as shown in the Drosophila larvae deficient for AK2 (ref. 9) . This enzyme regulates the homeostasis of cellular adenine nucleotides by converting ADP into ATP and AMP 9 and thus may be critical in specific key subcellular or extracellular compartments. Our observations in the inner ear suggest a new function for AK2 in the stria vascularis. Indeed, failure of the stria vascularis to produce the endocochlear potential or secrete K + in the endolymph results in hearing impairment 10, 11 . Moreover, serum ADP is thought to be one of the most damaging factors for endothelial integrity, in view of its proinflammatory and thrombotic effects 12 . In this respect, ecto-AK2 in the stria vascularis microvasculature might contribute to the control of local ADP levels via reverse transphosphorylation into ATP and AMP.
In many human and murine cells, AK2 is localized in the mitochondrial intermembrane space, suggesting a role for the protein in providing the energy required for the proliferation of hematopoietic precursors and/or in controlling cell apoptosis. With respect to the latter hypothesis, our findings are reminiscent of the results reported in another type of severe congenital neutropenia caused by HAX-1 deficiency 13 . HAX-1 is also located in the mitochondrial intermembrane space and is required to prevent apoptosis of mouse lymphocytes, granulocytes and neurons 14, 15 . AK2 might also be involved in the regulation of apoptosis via an as-yet-unknown mechanism that may involve its release from the mitochondria, together with cytochrome c 16, 17 . More recently, AK2 has been implicated in a newly identified intrinsic apoptosis pathway, where it forms a complex with FADD and caspase 10 (ref. 8) . In this latter report, truncated, mislocated AK2 products were found in the cytosol of human cells and were seen to induce apoptosis. However, our protein blot analysis did not reveal the presence of any truncated AK2 protein. This in agreement with the observation of a strong decrease in cell proliferation and survival as well as a block in myeloid differentiation induced by the downregulation of AK2 expression in CD34 + cells. The discrepancy with the published data may be related to the usage of different cell subsets: HeLa cells in the previous study 8 versus CD34 + cells in ours. Indeed, no effect on fibroblast cell survival was induced by downregulation of AK2. It is nevertheless possible that formation of an AK2-FADD-caspase 10 complex is required for commitment to the differentiation pathway of T and natural killer lymphoid cells as well as neutrophils. Indeed, the recent description of thrombocytopenia in individuals carrying mutations in the cytochrome c gene 18 emphasizes a possible lineage-specific control of caspase activation that may not be related to the classic cell death mechanism 19, 20 . Further investigation of the potential involvement of AK2 in regulating apoptosis in certain cell lineages is required.
We have identified mutations in human AK2 responsible for reticular dysgenesis, one of the most severe immunodeficiencies affecting both innate and adaptive immunity and associated with sensorineural deafness. These data emphasize the key role of the AK2 protein in hematopoiesis and identify a previously unknown celllineage restricted pathway controlling energy metabolism and/or cell growth and survival.
METHODS
Subjects. Seven families (each with one affected child) were analyzed in the present study. Three were unrelated consanguineous families (A, B, C), with two originating from Cape Verde (Western Africa) and the third from Turkey. The four other unrelated nonconsanguineous families originated from France (D), Portugal (E), The Netherlands (F) and Central America (G), respectively. All the probands were admitted to the hospital very soon after birth (from 1 day up to 1 month) because of multiple life-threatening infections. The blood cell count and the bone marrow status prompted a diagnosis of reticular dysgenesis. All of these individuals were later found to be deaf. All received an allogeneic hematopoietic stem cell transplant from one of the two parents or from phenocompatible cord blood (P6), which resulted in a cure in three (P3, P6, P7) of the seven individuals.
Genetic, sequencing and gene expression analysis. We carried out linkage analysis by homozygosity mapping 21 of the two Cape Verde families (A, B) and the Turkish family (C) at the Centre National de Genotypage (CNG, Evry, France), and we genotyped 17 additional microsatellite markers in the region of interest by using standard methods. DNA samples from the individuals with reticular dysgenesis and their relatives were purified from peripheral blood cells by using genomic DNA Maxiprep kits (Qiagen). For target gene sequencing, we designed PCR primers for the 2-Mb region and carried out standard Sanger sequencing at the US National Institutes of Health Intramural Sequencing Center (NISC). Coding regions of AK2 (exons 1-7) were completely covered by sequencing and had very high sequence-trace quality scores. Exons 1 and 7 had double sequence coverage (four traces per subject; two forward and two reverse traces). On average, each amplimer sequenced 645 targeted bases (median, 671; mode, 700). We processed traces to detect single nucleotide and insertion/ deletion (indel) variation using POLYPHRED software (version 6.11). We screened healthy individuals (100 chromosomes) for AK2 gene mutations and found none.
Cell samples and purification of human CD34 + cells. We harvested control human cord blood samples on delivery of full-term, healthy pregnancies at the Antoine Béclère Hospital and the Pitié-Salpetrière Hospital. Human bone marrow from individuals with reticular dysgenesis was collected under general anesthesia during the installation of the central line required for allogeneic bone marrow transplantation. Our study was performed with informed consent obtained from each subject or the subject's family and was approved by the Hôpital Necker independent ethics committee and the National Human Genome Research Institute institutional review board. Mononuclear cells (MNCs) and CD34 + cells were purified as previously described 22 .
For subjects P1, P3, P5 and P6, primary fibroblast cell lines were obtained from skin biopsies and fibroblasts were immortalized with SV40, as previously described 23 . B-EBV cell lines (EBV-transformed B-cell lines) were generated from bone marrow samples, as described elsewhere 24 .
In vitro myeloid differentiation assays. We evaluated the differentiation of CD34 + cells by clonal assay in methylcellulose (methoCult H4435), as previously described 22 . CD34 + cells were also cultured in X-Vivo 20 medium (BioWhittaker) supplemented with 10 ng/ml of stem cell factor (SCF, Amgen), and 100 ng/ml of granulocyte-macrophage colony stimulating factor (GM-CSF, Amgen) or 100 ng/ml granulocyte colony stimulating factor (G-CSF, Amgen). After 2 weeks, we harvested and analyzed cells by May-Grunwald-Giemsa staining. We also analyzed cells by flow cytometry using a combination of fluorescein isothiocyanate (FITC)-conjugated antibody to CD15 (anti-CD15, HI98), phycoerythrin (PE)-conjugated anti-CD11b (ICRF44) and allophycocyanin (APC)-conjugated anti-CD14 (M5E2) (Becton Dickinson, BD Biosciences). Analysis was done on a FACSCalibur (BD Biosciences) using the FlowJo software.
Gene expression analysis. Total RNA was reverse transcribed using random hexamers with MultiScribe MuLV reverse transcriptase (Applied Biosystems). RT-PCR was done on each subject sample using primers specific for AK2 and 28S (Supplementary Table 2 online) .
We carried out comparative real-time RT-PCR assays 25, 26 for each sample in triplicate in a final reaction volume of 50 ml. The endogenous gene (GAPDH) or the gene of interest (AK2A or AK2B) were amplified using around 20 ng of cDNA, and AK2A (Hs00761823), AK2B (Hs00797700) or GAPDH (Hs00266705) probes labeled with a FAM, 6-carboxy-fluorescein dye (Applied Biosystems). We carried out all reactions using an ABI Prism 7900 sequence detection system (Applied Biosystems). The data were analyzed using the comparative cycle threshold method and presented as the relative change in gene expression, normalized against the calibrator sample, corresponding to a fibroblast cell line.
Protein blots. Control or reticular dysgenesis fibroblast cell lines (either primary or SV40-transformed) were lysed in a buffer (containing 20mM Tris, pH 7.9; 300 mM NaCl; 1% Nonidet P-40) supplemented with protease and phosphatase inhibitors. Cell extracts were separated by SDS-PAGE, blotted and stained with a polyclonal antibody against AK2 (H65, Santa Cruz) or with a monoclonal antibody against b tubulin (TUB2.1, Sigma). After staining with an HRP-conjugated secondary antibody, the immunoblot was developed using an ECL+ kit (Amersham).
Construction and production of the lentiviral vectors. The backbone of the replication-defective, self-inactivating pWPI lentiviral vector was provided by Addgene. The constructs were generated using PmeI (Ozyme) ligation of the coding sequence of human AK2A (pWPI-AK2A) or AK2B (pWPI-AK2B). For construction of AK2 short hairpin RNA (shAK2) and the negative control Scramble shRNA (shScramble), the forward and reverse primers (Supplementary Table 2 ) containing target sequences from AK2 corresponding to the previously published shRNA#1 (ref. 8) and from a control Scramble were cloned into the MluI and ClaI sites of the pLVTHM lentiviral vector, provided by Addgene. The latter vectors enable coexpression of GFP under the control of an EF1a promoter. High-titer lentivirus supernatants were produced by Vectalys. Using this shAK2 lentivector, we effectively knocked down AK2 expression in cord blood-derived CD34 + cells as observed by quantitative RT-PCR (data not shown).
Transduction of human CD34 + cells. We cultured bone-marrow mononuclear cells or purified CD34 + cells overnight in X-vivo 20 medium supplemented with SCF (300 ng/ml), Flt3-ligand (Flt3-l, 300 ng/ml), interleukin 3 (60 ng/ml IL-3) and thrombopoietin (100 ng/ml TPO) (R&D Systems). Cells were then transferred onto culture plates coated with 50 mg/ml of retronectin-CH296 (Takara Bio) and transduced (at 2 Â 10 6 /ml) or not with the lentiviral supernatant (multiplicity of infection ¼ 100) in X-vivo 20 medium supplemented with the cytokines described above and 4 mg/ml of protamine sulfate (Choay). After an overnight culture, cells were harvested and seeded for the myeloid differentiation assay.
Immunofluorescence staining on inner ear sections. Experiments were done using 10-mm-thick, frozen cochlear sections. We prepared cochlear sections by dissecting the temporal bones and fixing them by immersion in 4% paraformaldehyde. The samples were then decalcified in 0.5 M EDTA, immersed in 20% sucrose and frozen in OCT compound embedding medium. After blocking in 20% goat serum, the sections were incubated with the primary antibody at 4 1C for 12 h, followed by incubation with the secondary antibody (and with phalloidin and/or Hoechst dyes) for 1 h at 25 1C and, lastly, embedded in Fluorsave (Calbiochem) for confocal microscopy analysis (with the LSM510 META from Zeiss). We used the following antibodies: polyclonal anti-AK2 (Abcam), Cy5 goat anti-rabbit Ig (H+L), Cy3 goat anti-mouse Ig (H+L) (Amersham) and Alexa Fluor 488-conjugated isolectin GS-IB4 (Invitrogen).
